Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care. Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye. See the future of eye care with Aerie.
View Top Employees from Aerie PharmaceuticalsWebsite | http://www.aeriepharma.com |
Ticker | AERI |
Revenue | $69 million |
Funding | $580.4 million |
Employees | 250 (250 on RocketReach) |
Founded | 2005 |
Address | 4301 Emperor Blvd., Durham, North Carolina 27703, US |
Phone | (919) 237-5300 |
Technologies |
JavaScript,
HTML,
PHP
+47 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
Keywords | Ophthalmic Care, Eye Care, Vision Care |
Competitors | AB Science, Deciphera Pharmaceuticals, G1 Therapeutics, Inc., Karyopharm Therapeutics Inc., Kite Pharma |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 33 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Aerie Pharmaceuticals employee's phone or email?
The Aerie Pharmaceuticals annual revenue was $69 million in 2024.
Craig Skenes is the Vice President, Business Development of Aerie Pharmaceuticals.
250 people are employed at Aerie Pharmaceuticals.
Aerie Pharmaceuticals is based in Durham, North Carolina.
The NAICS codes for Aerie Pharmaceuticals are [32541, 33, 325414, 3254, 325, 32].
The SIC codes for Aerie Pharmaceuticals are [28, 283].